End-stage renal disease attributable to diabetes mellitus

Annals of Internal Medicine

Volumn 121, Issue 12, 1994, Pages 912-918

  Perneger, Thomas V ^a   Brancati, Frederick L ^b   Whelton, Paul K ^b   Klag, Michael J ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT;

EID: 0027948488     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-121-12-199412150-00002     Document Type: Article

References (27)

1. U.S. Renal Data System. USRDS 1991 Annual data report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1991.
2. FitzSimmons SC, Agodoa L, Striker L, Conti F, Striker G. Kidney disease of diabetes mellitus: NIDDK initiatives for the comprehensive study of its natural history, pathogenesis, and prevention. Am J Kidney Dis. 1989;13:7-10.
3. Levin ML. The occurrence of lung cancer in man. Acta Unio International Contra Cancrum. 1953;19:531-41.
4. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York: John Wiley & Sons, Inc.; 1981.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86.
6. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med. 1989;111:788-96.
7. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type I diabetes. Am J Med. 1985;78:785-94.
8. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990;39:1116-24.
9. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in Type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983;25:496-501.
10. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T. Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark. Diabetes. 1987;36:205-9.
11. Klein R, Klein BE, Moss SE. The incidence of gross proteinuria in people with insulin-dependent diabetes mellitus. Arch Intern Med. 1991;151:1344-8.
12. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984;311:89-93.
13. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989;321:1074-9.
14. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA. 1992; 268:3079-84.
15. Perneger TV. Case-Control Study of Risk Factors for End-Stage Renal Disease (Dissertation). Baltimore: Johns Hopkins University; 1993.
16. Perneger TV, Myers TL, Klag MJ, Whelton PK. Evaluation of the Waksberg telephone sampling method for the selection of population controls. Am J Epidemiol. 1993;138:574-84.
17. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989:216-37.
18. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122:904-14.
19. Wilkinson L. SYSTAT: the system for statistics. Evanston, Illinois: SYSTAT, Inc.; 1990.
20. Gahlinger PM, Abramson JH. Computer Programs for Epidemiologic Studies. Honolulu: Makapuu Medical Press; 1993.
21. Perneger TV, Whelton PK, Klag MJ. Race and end-stage renal disease: socioeconomic status and access to health care as mediating factors. Arch Intern Med. 1995;[In press].
22. Richards NT, Greaves I, Lee SJ, Howie AJ, Adu D, Michael J. Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol Dial Transplant. 1992;7:397-9.
23. Midthjell K, Holmen J, Bjorndal A, Lund-Larsen G. Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trondelag diabetes study. J Epidemiol Community Health. 1992;46:537-42.
24. Perneger TV, Whelton PK, Klag MJ, Rossiter KA. Diagnosis of hypertensive end-stage renal disease: effect of patient's race. Am J Epidemiol. 1995;[In press].
25. Hamilton BP. Diabetes mellitus and hypertension. Am J Kidney Dis. 1990;16:20-9.
26. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-7.
27. Klag MJ, Whelton PK, Neaton JD, Randall B, Ford CE, Brancati FL, et al. Race and incidence of end-stage renal disease: A prospective study [Abstract]. Circulation. 1994;18:10.